KIA
GMAB icon

Knollwood Investment Advisory’s Genmab GMAB Stock Holding History

Knollwood Investment Advisory’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,300
Closed -$225K – 310
2025
Q4 		$225K Hold
7,300
– – 0.02% 312
2025
Q3 		$224K Buy
+7,300
New +$178K 0.02% 338
2024
Q2 		– Sell
-7,300
Closed -$218K – 351
2024
Q1 		$218K Hold
7,300
– – 0.04% 200
2023
Q4 		$232K Buy
+7,300
New +$229K 0.05% 196

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Knollwood Investment Advisory's GMAB Position: Q1 2026 in Review

Knollwood Investment Advisory sold out of Genmab (GMAB) in Q1 2026, closing a stake of 7,300 shares — an estimated $225K sold.

Knollwood Investment Advisory first reported a position in GMAB in Q4 2023 and held it in 4 quarters. The position peaked at $232K in Q4 2023. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Knollwood Investment Advisory reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Knollwood Investment Advisory sold 7,300 Genmab shares in Q1 2026, an estimated $225K.
  • Knollwood Investment Advisory first reported a position in Genmab in Q4 2023 and held it in 4 quarters.
  • Knollwood Investment Advisory's Genmab position peaked at $232K in Q4 2023.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Knollwood Investment Advisory's 13F filing for Q1 2026, filed 14 May 2026.